Global IDH1 Antibody Market Growth 2026-2032
The global IDH1 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IDH1 Antibody players cover Merck, GeneTex, Abcam, BosterBio, Proteintech Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “IDH1 Antibody Industry Forecast” looks at past sales and reviews total world IDH1 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected IDH1 Antibody sales for 2026 through 2032. With IDH1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IDH1 Antibody industry.
This Insight Report provides a comprehensive analysis of the global IDH1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IDH1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IDH1 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IDH1 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IDH1 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of IDH1 Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IDH1 Antibody market?
What factors are driving IDH1 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IDH1 Antibody market opportunities vary by end market size?
How does IDH1 Antibody break out by Type, by Application?
United States market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IDH1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IDH1 Antibody players cover Merck, GeneTex, Abcam, BosterBio, Proteintech Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “IDH1 Antibody Industry Forecast” looks at past sales and reviews total world IDH1 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected IDH1 Antibody sales for 2026 through 2032. With IDH1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IDH1 Antibody industry.
This Insight Report provides a comprehensive analysis of the global IDH1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IDH1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IDH1 Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IDH1 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IDH1 Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of IDH1 Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Immunoprecipitation (IP)
- Western Blot (WB)
- ELISA
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GeneTex
- Abcam
- BosterBio
- Proteintech Group
- Abnova Corporation
- Novus Biologicals
- NSJ Bioreagents
- LifeSpan BioSciences
- Abeomics
- ProSci
- QED Bioscience
- Cell Signaling Technology
- RayBiotech
- EpiGentek
- Enzo Life Sciences
- OriGene Technologies
- Jingjie PTM BioLab
- Beijing Solarbio
- Biobyt
What is the 10-year outlook for the global IDH1 Antibody market?
What factors are driving IDH1 Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IDH1 Antibody market opportunities vary by end market size?
How does IDH1 Antibody break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IDH1 Antibody Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IDH1 Antibody by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IDH1 Antibody by Country/Region, 2021, 2025 & 2032
2.2 IDH1 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.2.3 IDH1 Antibody Sales by Type
2.2.3.1 Global IDH1 Antibody Sales Market Share by Type (2021-2026)
2.2.3.2 Global IDH1 Antibody Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IDH1 Antibody Sale Price by Type (2021-2026)
2.3 IDH1 Antibody Segment by Application
2.3.1 Immunochemistry (IHC)
2.3.2 Immunofluorescence (IF)
2.3.3 Immunoprecipitation (IP)
2.3.4 Western Blot (WB)
2.3.5 ELISA
2.3.6 Others
2.3.7 IDH1 Antibody Sales by Application
2.3.7.1 Global IDH1 Antibody Sale Market Share by Application (2021-2026)
2.3.7.2 Global IDH1 Antibody Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global IDH1 Antibody Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IDH1 Antibody Breakdown Data by Company
3.1.1 Global IDH1 Antibody Annual Sales by Company (2021-2026)
3.1.2 Global IDH1 Antibody Sales Market Share by Company (2021-2026)
3.2 Global IDH1 Antibody Annual Revenue by Company (2021-2026)
3.2.1 Global IDH1 Antibody Revenue by Company (2021-2026)
3.2.2 Global IDH1 Antibody Revenue Market Share by Company (2021-2026)
3.3 Global IDH1 Antibody Sale Price by Company
3.4 Key Manufacturers IDH1 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IDH1 Antibody Product Location Distribution
3.4.2 Players IDH1 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IDH1 ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic IDH1 Antibody Market Size by Geographic Region (2021-2026)
4.1.1 Global IDH1 Antibody Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IDH1 Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IDH1 Antibody Market Size by Country/Region (2021-2026)
4.2.1 Global IDH1 Antibody Annual Sales by Country/Region (2021-2026)
4.2.2 Global IDH1 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas IDH1 Antibody Sales Growth
4.4 APAC IDH1 Antibody Sales Growth
4.5 Europe IDH1 Antibody Sales Growth
4.6 Middle East & Africa IDH1 Antibody Sales Growth
5 AMERICAS
5.1 Americas IDH1 Antibody Sales by Country
5.1.1 Americas IDH1 Antibody Sales by Country (2021-2026)
5.1.2 Americas IDH1 Antibody Revenue by Country (2021-2026)
5.2 Americas IDH1 Antibody Sales by Type (2021-2026)
5.3 Americas IDH1 Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IDH1 Antibody Sales by Region
6.1.1 APAC IDH1 Antibody Sales by Region (2021-2026)
6.1.2 APAC IDH1 Antibody Revenue by Region (2021-2026)
6.2 APAC IDH1 Antibody Sales by Type (2021-2026)
6.3 APAC IDH1 Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IDH1 Antibody by Country
7.1.1 Europe IDH1 Antibody Sales by Country (2021-2026)
7.1.2 Europe IDH1 Antibody Revenue by Country (2021-2026)
7.2 Europe IDH1 Antibody Sales by Type (2021-2026)
7.3 Europe IDH1 Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IDH1 Antibody by Country
8.1.1 Middle East & Africa IDH1 Antibody Sales by Country (2021-2026)
8.1.2 Middle East & Africa IDH1 Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa IDH1 Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa IDH1 Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IDH1 Antibody
10.3 Manufacturing Process Analysis of IDH1 Antibody
10.4 Industry Chain Structure of IDH1 Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IDH1 Antibody Distributors
11.3 IDH1 Antibody Customer
12 WORLD FORECAST REVIEW FOR IDH1 ANTIBODY BY GEOGRAPHIC REGION
12.1 Global IDH1 Antibody Market Size Forecast by Region
12.1.1 Global IDH1 Antibody Forecast by Region (2027-2032)
12.1.2 Global IDH1 Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IDH1 Antibody Forecast by Type (2027-2032)
12.7 Global IDH1 Antibody Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck IDH1 Antibody Product Portfolios and Specifications
13.1.3 Merck IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GeneTex
13.2.1 GeneTex Company Information
13.2.2 GeneTex IDH1 Antibody Product Portfolios and Specifications
13.2.3 GeneTex IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GeneTex Main Business Overview
13.2.5 GeneTex Latest Developments
13.3 Abcam
13.3.1 Abcam Company Information
13.3.2 Abcam IDH1 Antibody Product Portfolios and Specifications
13.3.3 Abcam IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abcam Main Business Overview
13.3.5 Abcam Latest Developments
13.4 BosterBio
13.4.1 BosterBio Company Information
13.4.2 BosterBio IDH1 Antibody Product Portfolios and Specifications
13.4.3 BosterBio IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BosterBio Main Business Overview
13.4.5 BosterBio Latest Developments
13.5 Proteintech Group
13.5.1 Proteintech Group Company Information
13.5.2 Proteintech Group IDH1 Antibody Product Portfolios and Specifications
13.5.3 Proteintech Group IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Proteintech Group Main Business Overview
13.5.5 Proteintech Group Latest Developments
13.6 Abnova Corporation
13.6.1 Abnova Corporation Company Information
13.6.2 Abnova Corporation IDH1 Antibody Product Portfolios and Specifications
13.6.3 Abnova Corporation IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Abnova Corporation Main Business Overview
13.6.5 Abnova Corporation Latest Developments
13.7 Novus Biologicals
13.7.1 Novus Biologicals Company Information
13.7.2 Novus Biologicals IDH1 Antibody Product Portfolios and Specifications
13.7.3 Novus Biologicals IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novus Biologicals Main Business Overview
13.7.5 Novus Biologicals Latest Developments
13.8 NSJ Bioreagents
13.8.1 NSJ Bioreagents Company Information
13.8.2 NSJ Bioreagents IDH1 Antibody Product Portfolios and Specifications
13.8.3 NSJ Bioreagents IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 NSJ Bioreagents Main Business Overview
13.8.5 NSJ Bioreagents Latest Developments
13.9 LifeSpan BioSciences
13.9.1 LifeSpan BioSciences Company Information
13.9.2 LifeSpan BioSciences IDH1 Antibody Product Portfolios and Specifications
13.9.3 LifeSpan BioSciences IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 LifeSpan BioSciences Main Business Overview
13.9.5 LifeSpan BioSciences Latest Developments
13.10 Abeomics
13.10.1 Abeomics Company Information
13.10.2 Abeomics IDH1 Antibody Product Portfolios and Specifications
13.10.3 Abeomics IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Abeomics Main Business Overview
13.10.5 Abeomics Latest Developments
13.11 ProSci
13.11.1 ProSci Company Information
13.11.2 ProSci IDH1 Antibody Product Portfolios and Specifications
13.11.3 ProSci IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ProSci Main Business Overview
13.11.5 ProSci Latest Developments
13.12 QED Bioscience
13.12.1 QED Bioscience Company Information
13.12.2 QED Bioscience IDH1 Antibody Product Portfolios and Specifications
13.12.3 QED Bioscience IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 QED Bioscience Main Business Overview
13.12.5 QED Bioscience Latest Developments
13.13 Cell Signaling Technology
13.13.1 Cell Signaling Technology Company Information
13.13.2 Cell Signaling Technology IDH1 Antibody Product Portfolios and Specifications
13.13.3 Cell Signaling Technology IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Cell Signaling Technology Main Business Overview
13.13.5 Cell Signaling Technology Latest Developments
13.14 RayBiotech
13.14.1 RayBiotech Company Information
13.14.2 RayBiotech IDH1 Antibody Product Portfolios and Specifications
13.14.3 RayBiotech IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 RayBiotech Main Business Overview
13.14.5 RayBiotech Latest Developments
13.15 EpiGentek
13.15.1 EpiGentek Company Information
13.15.2 EpiGentek IDH1 Antibody Product Portfolios and Specifications
13.15.3 EpiGentek IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 EpiGentek Main Business Overview
13.15.5 EpiGentek Latest Developments
13.16 Enzo Life Sciences
13.16.1 Enzo Life Sciences Company Information
13.16.2 Enzo Life Sciences IDH1 Antibody Product Portfolios and Specifications
13.16.3 Enzo Life Sciences IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Enzo Life Sciences Main Business Overview
13.16.5 Enzo Life Sciences Latest Developments
13.17 OriGene Technologies
13.17.1 OriGene Technologies Company Information
13.17.2 OriGene Technologies IDH1 Antibody Product Portfolios and Specifications
13.17.3 OriGene Technologies IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 OriGene Technologies Main Business Overview
13.17.5 OriGene Technologies Latest Developments
13.18 Jingjie PTM BioLab
13.18.1 Jingjie PTM BioLab Company Information
13.18.2 Jingjie PTM BioLab IDH1 Antibody Product Portfolios and Specifications
13.18.3 Jingjie PTM BioLab IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jingjie PTM BioLab Main Business Overview
13.18.5 Jingjie PTM BioLab Latest Developments
13.19 Beijing Solarbio
13.19.1 Beijing Solarbio Company Information
13.19.2 Beijing Solarbio IDH1 Antibody Product Portfolios and Specifications
13.19.3 Beijing Solarbio IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Beijing Solarbio Main Business Overview
13.19.5 Beijing Solarbio Latest Developments
13.20 Biobyt
13.20.1 Biobyt Company Information
13.20.2 Biobyt IDH1 Antibody Product Portfolios and Specifications
13.20.3 Biobyt IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Biobyt Main Business Overview
13.20.5 Biobyt Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IDH1 Antibody Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IDH1 Antibody by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IDH1 Antibody by Country/Region, 2021, 2025 & 2032
2.2 IDH1 Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.2.3 IDH1 Antibody Sales by Type
2.2.3.1 Global IDH1 Antibody Sales Market Share by Type (2021-2026)
2.2.3.2 Global IDH1 Antibody Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IDH1 Antibody Sale Price by Type (2021-2026)
2.3 IDH1 Antibody Segment by Application
2.3.1 Immunochemistry (IHC)
2.3.2 Immunofluorescence (IF)
2.3.3 Immunoprecipitation (IP)
2.3.4 Western Blot (WB)
2.3.5 ELISA
2.3.6 Others
2.3.7 IDH1 Antibody Sales by Application
2.3.7.1 Global IDH1 Antibody Sale Market Share by Application (2021-2026)
2.3.7.2 Global IDH1 Antibody Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global IDH1 Antibody Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IDH1 Antibody Breakdown Data by Company
3.1.1 Global IDH1 Antibody Annual Sales by Company (2021-2026)
3.1.2 Global IDH1 Antibody Sales Market Share by Company (2021-2026)
3.2 Global IDH1 Antibody Annual Revenue by Company (2021-2026)
3.2.1 Global IDH1 Antibody Revenue by Company (2021-2026)
3.2.2 Global IDH1 Antibody Revenue Market Share by Company (2021-2026)
3.3 Global IDH1 Antibody Sale Price by Company
3.4 Key Manufacturers IDH1 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IDH1 Antibody Product Location Distribution
3.4.2 Players IDH1 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IDH1 ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic IDH1 Antibody Market Size by Geographic Region (2021-2026)
4.1.1 Global IDH1 Antibody Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IDH1 Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IDH1 Antibody Market Size by Country/Region (2021-2026)
4.2.1 Global IDH1 Antibody Annual Sales by Country/Region (2021-2026)
4.2.2 Global IDH1 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas IDH1 Antibody Sales Growth
4.4 APAC IDH1 Antibody Sales Growth
4.5 Europe IDH1 Antibody Sales Growth
4.6 Middle East & Africa IDH1 Antibody Sales Growth
5 AMERICAS
5.1 Americas IDH1 Antibody Sales by Country
5.1.1 Americas IDH1 Antibody Sales by Country (2021-2026)
5.1.2 Americas IDH1 Antibody Revenue by Country (2021-2026)
5.2 Americas IDH1 Antibody Sales by Type (2021-2026)
5.3 Americas IDH1 Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IDH1 Antibody Sales by Region
6.1.1 APAC IDH1 Antibody Sales by Region (2021-2026)
6.1.2 APAC IDH1 Antibody Revenue by Region (2021-2026)
6.2 APAC IDH1 Antibody Sales by Type (2021-2026)
6.3 APAC IDH1 Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IDH1 Antibody by Country
7.1.1 Europe IDH1 Antibody Sales by Country (2021-2026)
7.1.2 Europe IDH1 Antibody Revenue by Country (2021-2026)
7.2 Europe IDH1 Antibody Sales by Type (2021-2026)
7.3 Europe IDH1 Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IDH1 Antibody by Country
8.1.1 Middle East & Africa IDH1 Antibody Sales by Country (2021-2026)
8.1.2 Middle East & Africa IDH1 Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa IDH1 Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa IDH1 Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IDH1 Antibody
10.3 Manufacturing Process Analysis of IDH1 Antibody
10.4 Industry Chain Structure of IDH1 Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IDH1 Antibody Distributors
11.3 IDH1 Antibody Customer
12 WORLD FORECAST REVIEW FOR IDH1 ANTIBODY BY GEOGRAPHIC REGION
12.1 Global IDH1 Antibody Market Size Forecast by Region
12.1.1 Global IDH1 Antibody Forecast by Region (2027-2032)
12.1.2 Global IDH1 Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IDH1 Antibody Forecast by Type (2027-2032)
12.7 Global IDH1 Antibody Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck IDH1 Antibody Product Portfolios and Specifications
13.1.3 Merck IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GeneTex
13.2.1 GeneTex Company Information
13.2.2 GeneTex IDH1 Antibody Product Portfolios and Specifications
13.2.3 GeneTex IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GeneTex Main Business Overview
13.2.5 GeneTex Latest Developments
13.3 Abcam
13.3.1 Abcam Company Information
13.3.2 Abcam IDH1 Antibody Product Portfolios and Specifications
13.3.3 Abcam IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abcam Main Business Overview
13.3.5 Abcam Latest Developments
13.4 BosterBio
13.4.1 BosterBio Company Information
13.4.2 BosterBio IDH1 Antibody Product Portfolios and Specifications
13.4.3 BosterBio IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BosterBio Main Business Overview
13.4.5 BosterBio Latest Developments
13.5 Proteintech Group
13.5.1 Proteintech Group Company Information
13.5.2 Proteintech Group IDH1 Antibody Product Portfolios and Specifications
13.5.3 Proteintech Group IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Proteintech Group Main Business Overview
13.5.5 Proteintech Group Latest Developments
13.6 Abnova Corporation
13.6.1 Abnova Corporation Company Information
13.6.2 Abnova Corporation IDH1 Antibody Product Portfolios and Specifications
13.6.3 Abnova Corporation IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Abnova Corporation Main Business Overview
13.6.5 Abnova Corporation Latest Developments
13.7 Novus Biologicals
13.7.1 Novus Biologicals Company Information
13.7.2 Novus Biologicals IDH1 Antibody Product Portfolios and Specifications
13.7.3 Novus Biologicals IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novus Biologicals Main Business Overview
13.7.5 Novus Biologicals Latest Developments
13.8 NSJ Bioreagents
13.8.1 NSJ Bioreagents Company Information
13.8.2 NSJ Bioreagents IDH1 Antibody Product Portfolios and Specifications
13.8.3 NSJ Bioreagents IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 NSJ Bioreagents Main Business Overview
13.8.5 NSJ Bioreagents Latest Developments
13.9 LifeSpan BioSciences
13.9.1 LifeSpan BioSciences Company Information
13.9.2 LifeSpan BioSciences IDH1 Antibody Product Portfolios and Specifications
13.9.3 LifeSpan BioSciences IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 LifeSpan BioSciences Main Business Overview
13.9.5 LifeSpan BioSciences Latest Developments
13.10 Abeomics
13.10.1 Abeomics Company Information
13.10.2 Abeomics IDH1 Antibody Product Portfolios and Specifications
13.10.3 Abeomics IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Abeomics Main Business Overview
13.10.5 Abeomics Latest Developments
13.11 ProSci
13.11.1 ProSci Company Information
13.11.2 ProSci IDH1 Antibody Product Portfolios and Specifications
13.11.3 ProSci IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ProSci Main Business Overview
13.11.5 ProSci Latest Developments
13.12 QED Bioscience
13.12.1 QED Bioscience Company Information
13.12.2 QED Bioscience IDH1 Antibody Product Portfolios and Specifications
13.12.3 QED Bioscience IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 QED Bioscience Main Business Overview
13.12.5 QED Bioscience Latest Developments
13.13 Cell Signaling Technology
13.13.1 Cell Signaling Technology Company Information
13.13.2 Cell Signaling Technology IDH1 Antibody Product Portfolios and Specifications
13.13.3 Cell Signaling Technology IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Cell Signaling Technology Main Business Overview
13.13.5 Cell Signaling Technology Latest Developments
13.14 RayBiotech
13.14.1 RayBiotech Company Information
13.14.2 RayBiotech IDH1 Antibody Product Portfolios and Specifications
13.14.3 RayBiotech IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 RayBiotech Main Business Overview
13.14.5 RayBiotech Latest Developments
13.15 EpiGentek
13.15.1 EpiGentek Company Information
13.15.2 EpiGentek IDH1 Antibody Product Portfolios and Specifications
13.15.3 EpiGentek IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 EpiGentek Main Business Overview
13.15.5 EpiGentek Latest Developments
13.16 Enzo Life Sciences
13.16.1 Enzo Life Sciences Company Information
13.16.2 Enzo Life Sciences IDH1 Antibody Product Portfolios and Specifications
13.16.3 Enzo Life Sciences IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Enzo Life Sciences Main Business Overview
13.16.5 Enzo Life Sciences Latest Developments
13.17 OriGene Technologies
13.17.1 OriGene Technologies Company Information
13.17.2 OriGene Technologies IDH1 Antibody Product Portfolios and Specifications
13.17.3 OriGene Technologies IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 OriGene Technologies Main Business Overview
13.17.5 OriGene Technologies Latest Developments
13.18 Jingjie PTM BioLab
13.18.1 Jingjie PTM BioLab Company Information
13.18.2 Jingjie PTM BioLab IDH1 Antibody Product Portfolios and Specifications
13.18.3 Jingjie PTM BioLab IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jingjie PTM BioLab Main Business Overview
13.18.5 Jingjie PTM BioLab Latest Developments
13.19 Beijing Solarbio
13.19.1 Beijing Solarbio Company Information
13.19.2 Beijing Solarbio IDH1 Antibody Product Portfolios and Specifications
13.19.3 Beijing Solarbio IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Beijing Solarbio Main Business Overview
13.19.5 Beijing Solarbio Latest Developments
13.20 Biobyt
13.20.1 Biobyt Company Information
13.20.2 Biobyt IDH1 Antibody Product Portfolios and Specifications
13.20.3 Biobyt IDH1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Biobyt Main Business Overview
13.20.5 Biobyt Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IDH1 Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IDH1 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 6. Global IDH1 Antibody Sales Market Share by Type (2021-2026)
Table 7. Global IDH1 Antibody Revenue by Type (2021-2026) & ($ million)
Table 8. Global IDH1 Antibody Revenue Market Share by Type (2021-2026)
Table 9. Global IDH1 Antibody Sale Price by Type (2021-2026) & (US$/ml)
Table 10. Global IDH1 Antibody Sale by Application (2021-2026) & (ml)
Table 11. Global IDH1 Antibody Sale Market Share by Application (2021-2026)
Table 12. Global IDH1 Antibody Revenue by Application (2021-2026) & ($ million)
Table 13. Global IDH1 Antibody Revenue Market Share by Application (2021-2026)
Table 14. Global IDH1 Antibody Sale Price by Application (2021-2026) & (US$/ml)
Table 15. Global IDH1 Antibody Sales by Company (2021-2026) & (ml)
Table 16. Global IDH1 Antibody Sales Market Share by Company (2021-2026)
Table 17. Global IDH1 Antibody Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IDH1 Antibody Revenue Market Share by Company (2021-2026)
Table 19. Global IDH1 Antibody Sale Price by Company (2021-2026) & (US$/ml)
Table 20. Key Manufacturers IDH1 Antibody Producing Area Distribution and Sales Area
Table 21. Players IDH1 Antibody Products Offered
Table 22. IDH1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IDH1 Antibody Sales by Geographic Region (2021-2026) & (ml)
Table 26. Global IDH1 Antibody Sales Market Share Geographic Region (2021-2026)
Table 27. Global IDH1 Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IDH1 Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IDH1 Antibody Sales by Country/Region (2021-2026) & (ml)
Table 30. Global IDH1 Antibody Sales Market Share by Country/Region (2021-2026)
Table 31. Global IDH1 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IDH1 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 34. Americas IDH1 Antibody Sales Market Share by Country (2021-2026)
Table 35. Americas IDH1 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 37. Americas IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 38. APAC IDH1 Antibody Sales by Region (2021-2026) & (ml)
Table 39. APAC IDH1 Antibody Sales Market Share by Region (2021-2026)
Table 40. APAC IDH1 Antibody Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 42. APAC IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 43. Europe IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 44. Europe IDH1 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 46. Europe IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 47. Middle East & Africa IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 48. Middle East & Africa IDH1 Antibody Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 50. Middle East & Africa IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 51. Key Market Drivers & Growth Opportunities of IDH1 Antibody
Table 52. Key Market Challenges & Risks of IDH1 Antibody
Table 53. Key Industry Trends of IDH1 Antibody
Table 54. IDH1 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IDH1 Antibody Distributors List
Table 57. IDH1 Antibody Customer List
Table 58. Global IDH1 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 59. Global IDH1 Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 61. Americas IDH1 Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IDH1 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 63. APAC IDH1 Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 65. Europe IDH1 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 67. Middle East & Africa IDH1 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IDH1 Antibody Sales Forecast by Type (2027-2032) & (ml)
Table 69. Global IDH1 Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IDH1 Antibody Sales Forecast by Application (2027-2032) & (ml)
Table 71. Global IDH1 Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck IDH1 Antibody Product Portfolios and Specifications
Table 74. Merck IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GeneTex Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. GeneTex IDH1 Antibody Product Portfolios and Specifications
Table 79. GeneTex IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 80. GeneTex Main Business
Table 81. GeneTex Latest Developments
Table 82. Abcam Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. Abcam IDH1 Antibody Product Portfolios and Specifications
Table 84. Abcam IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 85. Abcam Main Business
Table 86. Abcam Latest Developments
Table 87. BosterBio Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. BosterBio IDH1 Antibody Product Portfolios and Specifications
Table 89. BosterBio IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 90. BosterBio Main Business
Table 91. BosterBio Latest Developments
Table 92. Proteintech Group Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Proteintech Group IDH1 Antibody Product Portfolios and Specifications
Table 94. Proteintech Group IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 95. Proteintech Group Main Business
Table 96. Proteintech Group Latest Developments
Table 97. Abnova Corporation Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. Abnova Corporation IDH1 Antibody Product Portfolios and Specifications
Table 99. Abnova Corporation IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 100. Abnova Corporation Main Business
Table 101. Abnova Corporation Latest Developments
Table 102. Novus Biologicals Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. Novus Biologicals IDH1 Antibody Product Portfolios and Specifications
Table 104. Novus Biologicals IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 105. Novus Biologicals Main Business
Table 106. Novus Biologicals Latest Developments
Table 107. NSJ Bioreagents Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. NSJ Bioreagents IDH1 Antibody Product Portfolios and Specifications
Table 109. NSJ Bioreagents IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 110. NSJ Bioreagents Main Business
Table 111. NSJ Bioreagents Latest Developments
Table 112. LifeSpan BioSciences Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. LifeSpan BioSciences IDH1 Antibody Product Portfolios and Specifications
Table 114. LifeSpan BioSciences IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 115. LifeSpan BioSciences Main Business
Table 116. LifeSpan BioSciences Latest Developments
Table 117. Abeomics Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Abeomics IDH1 Antibody Product Portfolios and Specifications
Table 119. Abeomics IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 120. Abeomics Main Business
Table 121. Abeomics Latest Developments
Table 122. ProSci Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. ProSci IDH1 Antibody Product Portfolios and Specifications
Table 124. ProSci IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 125. ProSci Main Business
Table 126. ProSci Latest Developments
Table 127. QED Bioscience Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. QED Bioscience IDH1 Antibody Product Portfolios and Specifications
Table 129. QED Bioscience IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 130. QED Bioscience Main Business
Table 131. QED Bioscience Latest Developments
Table 132. Cell Signaling Technology Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. Cell Signaling Technology IDH1 Antibody Product Portfolios and Specifications
Table 134. Cell Signaling Technology IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 135. Cell Signaling Technology Main Business
Table 136. Cell Signaling Technology Latest Developments
Table 137. RayBiotech Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. RayBiotech IDH1 Antibody Product Portfolios and Specifications
Table 139. RayBiotech IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 140. RayBiotech Main Business
Table 141. RayBiotech Latest Developments
Table 142. EpiGentek Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. EpiGentek IDH1 Antibody Product Portfolios and Specifications
Table 144. EpiGentek IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 145. EpiGentek Main Business
Table 146. EpiGentek Latest Developments
Table 147. Enzo Life Sciences Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Enzo Life Sciences IDH1 Antibody Product Portfolios and Specifications
Table 149. Enzo Life Sciences IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 150. Enzo Life Sciences Main Business
Table 151. Enzo Life Sciences Latest Developments
Table 152. OriGene Technologies Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. OriGene Technologies IDH1 Antibody Product Portfolios and Specifications
Table 154. OriGene Technologies IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 155. OriGene Technologies Main Business
Table 156. OriGene Technologies Latest Developments
Table 157. Jingjie PTM BioLab Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. Jingjie PTM BioLab IDH1 Antibody Product Portfolios and Specifications
Table 159. Jingjie PTM BioLab IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 160. Jingjie PTM BioLab Main Business
Table 161. Jingjie PTM BioLab Latest Developments
Table 162. Beijing Solarbio Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Solarbio IDH1 Antibody Product Portfolios and Specifications
Table 164. Beijing Solarbio IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 165. Beijing Solarbio Main Business
Table 166. Beijing Solarbio Latest Developments
Table 167. Biobyt Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 168. Biobyt IDH1 Antibody Product Portfolios and Specifications
Table 169. Biobyt IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 170. Biobyt Main Business
Table 171. Biobyt Latest Developments
Table 1. IDH1 Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IDH1 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 6. Global IDH1 Antibody Sales Market Share by Type (2021-2026)
Table 7. Global IDH1 Antibody Revenue by Type (2021-2026) & ($ million)
Table 8. Global IDH1 Antibody Revenue Market Share by Type (2021-2026)
Table 9. Global IDH1 Antibody Sale Price by Type (2021-2026) & (US$/ml)
Table 10. Global IDH1 Antibody Sale by Application (2021-2026) & (ml)
Table 11. Global IDH1 Antibody Sale Market Share by Application (2021-2026)
Table 12. Global IDH1 Antibody Revenue by Application (2021-2026) & ($ million)
Table 13. Global IDH1 Antibody Revenue Market Share by Application (2021-2026)
Table 14. Global IDH1 Antibody Sale Price by Application (2021-2026) & (US$/ml)
Table 15. Global IDH1 Antibody Sales by Company (2021-2026) & (ml)
Table 16. Global IDH1 Antibody Sales Market Share by Company (2021-2026)
Table 17. Global IDH1 Antibody Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IDH1 Antibody Revenue Market Share by Company (2021-2026)
Table 19. Global IDH1 Antibody Sale Price by Company (2021-2026) & (US$/ml)
Table 20. Key Manufacturers IDH1 Antibody Producing Area Distribution and Sales Area
Table 21. Players IDH1 Antibody Products Offered
Table 22. IDH1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IDH1 Antibody Sales by Geographic Region (2021-2026) & (ml)
Table 26. Global IDH1 Antibody Sales Market Share Geographic Region (2021-2026)
Table 27. Global IDH1 Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IDH1 Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IDH1 Antibody Sales by Country/Region (2021-2026) & (ml)
Table 30. Global IDH1 Antibody Sales Market Share by Country/Region (2021-2026)
Table 31. Global IDH1 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IDH1 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 34. Americas IDH1 Antibody Sales Market Share by Country (2021-2026)
Table 35. Americas IDH1 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 37. Americas IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 38. APAC IDH1 Antibody Sales by Region (2021-2026) & (ml)
Table 39. APAC IDH1 Antibody Sales Market Share by Region (2021-2026)
Table 40. APAC IDH1 Antibody Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 42. APAC IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 43. Europe IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 44. Europe IDH1 Antibody Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 46. Europe IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 47. Middle East & Africa IDH1 Antibody Sales by Country (2021-2026) & (ml)
Table 48. Middle East & Africa IDH1 Antibody Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IDH1 Antibody Sales by Type (2021-2026) & (ml)
Table 50. Middle East & Africa IDH1 Antibody Sales by Application (2021-2026) & (ml)
Table 51. Key Market Drivers & Growth Opportunities of IDH1 Antibody
Table 52. Key Market Challenges & Risks of IDH1 Antibody
Table 53. Key Industry Trends of IDH1 Antibody
Table 54. IDH1 Antibody Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IDH1 Antibody Distributors List
Table 57. IDH1 Antibody Customer List
Table 58. Global IDH1 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 59. Global IDH1 Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 61. Americas IDH1 Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IDH1 Antibody Sales Forecast by Region (2027-2032) & (ml)
Table 63. APAC IDH1 Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 65. Europe IDH1 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IDH1 Antibody Sales Forecast by Country (2027-2032) & (ml)
Table 67. Middle East & Africa IDH1 Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IDH1 Antibody Sales Forecast by Type (2027-2032) & (ml)
Table 69. Global IDH1 Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IDH1 Antibody Sales Forecast by Application (2027-2032) & (ml)
Table 71. Global IDH1 Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck IDH1 Antibody Product Portfolios and Specifications
Table 74. Merck IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GeneTex Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 78. GeneTex IDH1 Antibody Product Portfolios and Specifications
Table 79. GeneTex IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 80. GeneTex Main Business
Table 81. GeneTex Latest Developments
Table 82. Abcam Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 83. Abcam IDH1 Antibody Product Portfolios and Specifications
Table 84. Abcam IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 85. Abcam Main Business
Table 86. Abcam Latest Developments
Table 87. BosterBio Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 88. BosterBio IDH1 Antibody Product Portfolios and Specifications
Table 89. BosterBio IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 90. BosterBio Main Business
Table 91. BosterBio Latest Developments
Table 92. Proteintech Group Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Proteintech Group IDH1 Antibody Product Portfolios and Specifications
Table 94. Proteintech Group IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 95. Proteintech Group Main Business
Table 96. Proteintech Group Latest Developments
Table 97. Abnova Corporation Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. Abnova Corporation IDH1 Antibody Product Portfolios and Specifications
Table 99. Abnova Corporation IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 100. Abnova Corporation Main Business
Table 101. Abnova Corporation Latest Developments
Table 102. Novus Biologicals Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. Novus Biologicals IDH1 Antibody Product Portfolios and Specifications
Table 104. Novus Biologicals IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 105. Novus Biologicals Main Business
Table 106. Novus Biologicals Latest Developments
Table 107. NSJ Bioreagents Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. NSJ Bioreagents IDH1 Antibody Product Portfolios and Specifications
Table 109. NSJ Bioreagents IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 110. NSJ Bioreagents Main Business
Table 111. NSJ Bioreagents Latest Developments
Table 112. LifeSpan BioSciences Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. LifeSpan BioSciences IDH1 Antibody Product Portfolios and Specifications
Table 114. LifeSpan BioSciences IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 115. LifeSpan BioSciences Main Business
Table 116. LifeSpan BioSciences Latest Developments
Table 117. Abeomics Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Abeomics IDH1 Antibody Product Portfolios and Specifications
Table 119. Abeomics IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 120. Abeomics Main Business
Table 121. Abeomics Latest Developments
Table 122. ProSci Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. ProSci IDH1 Antibody Product Portfolios and Specifications
Table 124. ProSci IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 125. ProSci Main Business
Table 126. ProSci Latest Developments
Table 127. QED Bioscience Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. QED Bioscience IDH1 Antibody Product Portfolios and Specifications
Table 129. QED Bioscience IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 130. QED Bioscience Main Business
Table 131. QED Bioscience Latest Developments
Table 132. Cell Signaling Technology Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. Cell Signaling Technology IDH1 Antibody Product Portfolios and Specifications
Table 134. Cell Signaling Technology IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 135. Cell Signaling Technology Main Business
Table 136. Cell Signaling Technology Latest Developments
Table 137. RayBiotech Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. RayBiotech IDH1 Antibody Product Portfolios and Specifications
Table 139. RayBiotech IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 140. RayBiotech Main Business
Table 141. RayBiotech Latest Developments
Table 142. EpiGentek Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. EpiGentek IDH1 Antibody Product Portfolios and Specifications
Table 144. EpiGentek IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 145. EpiGentek Main Business
Table 146. EpiGentek Latest Developments
Table 147. Enzo Life Sciences Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Enzo Life Sciences IDH1 Antibody Product Portfolios and Specifications
Table 149. Enzo Life Sciences IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 150. Enzo Life Sciences Main Business
Table 151. Enzo Life Sciences Latest Developments
Table 152. OriGene Technologies Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. OriGene Technologies IDH1 Antibody Product Portfolios and Specifications
Table 154. OriGene Technologies IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 155. OriGene Technologies Main Business
Table 156. OriGene Technologies Latest Developments
Table 157. Jingjie PTM BioLab Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. Jingjie PTM BioLab IDH1 Antibody Product Portfolios and Specifications
Table 159. Jingjie PTM BioLab IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 160. Jingjie PTM BioLab Main Business
Table 161. Jingjie PTM BioLab Latest Developments
Table 162. Beijing Solarbio Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Solarbio IDH1 Antibody Product Portfolios and Specifications
Table 164. Beijing Solarbio IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 165. Beijing Solarbio Main Business
Table 166. Beijing Solarbio Latest Developments
Table 167. Biobyt Basic Information, IDH1 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 168. Biobyt IDH1 Antibody Product Portfolios and Specifications
Table 169. Biobyt IDH1 Antibody Sales (ml), Revenue ($ Million), Price (US$/ml) and Gross Margin (2021-2026)
Table 170. Biobyt Main Business
Table 171. Biobyt Latest Developments
LIST OF FIGURES
Figure 1. Picture of IDH1 Antibody
Figure 2. IDH1 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IDH1 Antibody Sales Growth Rate 2021-2032 (ml)
Figure 7. Global IDH1 Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IDH1 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IDH1 Antibody Sales Market Share by Country/Region (2025)
Figure 10. IDH1 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global IDH1 Antibody Sales Market Share by Type in 2026
Figure 14. Global IDH1 Antibody Revenue Market Share by Type (2021-2026)
Figure 15. IDH1 Antibody Consumed in Immunochemistry (IHC)
Figure 16. Global IDH1 Antibody Market: Immunochemistry (IHC) (2021-2026) & (ml)
Figure 17. IDH1 Antibody Consumed in Immunofluorescence (IF)
Figure 18. Global IDH1 Antibody Market: Immunofluorescence (IF) (2021-2026) & (ml)
Figure 19. IDH1 Antibody Consumed in Immunoprecipitation (IP)
Figure 20. Global IDH1 Antibody Market: Immunoprecipitation (IP) (2021-2026) & (ml)
Figure 21. IDH1 Antibody Consumed in Western Blot (WB)
Figure 22. Global IDH1 Antibody Market: Western Blot (WB) (2021-2026) & (ml)
Figure 23. IDH1 Antibody Consumed in ELISA
Figure 24. Global IDH1 Antibody Market: ELISA (2021-2026) & (ml)
Figure 25. IDH1 Antibody Consumed in Others
Figure 26. Global IDH1 Antibody Market: Others (2021-2026) & (ml)
Figure 27. Global IDH1 Antibody Sale Market Share by Application (2025)
Figure 28. Global IDH1 Antibody Revenue Market Share by Application in 2026
Figure 29. IDH1 Antibody Sales by Company in 2026 (ml)
Figure 30. Global IDH1 Antibody Sales Market Share by Company in 2026
Figure 31. IDH1 Antibody Revenue by Company in 2026 ($ millions)
Figure 32. Global IDH1 Antibody Revenue Market Share by Company in 2026
Figure 33. Global IDH1 Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global IDH1 Antibody Revenue Market Share by Geographic Region in 2026
Figure 35. Americas IDH1 Antibody Sales 2021-2026 (ml)
Figure 36. Americas IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 37. APAC IDH1 Antibody Sales 2021-2026 (ml)
Figure 38. APAC IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 39. Europe IDH1 Antibody Sales 2021-2026 (ml)
Figure 40. Europe IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa IDH1 Antibody Sales 2021-2026 (ml)
Figure 42. Middle East & Africa IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 43. Americas IDH1 Antibody Sales Market Share by Country in 2026
Figure 44. Americas IDH1 Antibody Revenue Market Share by Country (2021-2026)
Figure 45. Americas IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 46. Americas IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 47. United States IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC IDH1 Antibody Sales Market Share by Region in 2026
Figure 52. APAC IDH1 Antibody Revenue Market Share by Region (2021-2026)
Figure 53. APAC IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 54. APAC IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 55. China IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. India IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe IDH1 Antibody Sales Market Share by Country in 2026
Figure 63. Europe IDH1 Antibody Revenue Market Share by Country (2021-2026)
Figure 64. Europe IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 65. Europe IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 66. Germany IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. France IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. UK IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa IDH1 Antibody Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 74. Egypt IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of IDH1 Antibody in 2026
Figure 80. Manufacturing Process Analysis of IDH1 Antibody
Figure 81. Industry Chain Structure of IDH1 Antibody
Figure 82. Channels of Distribution
Figure 83. Global IDH1 Antibody Sales Market Forecast by Region (2027-2032)
Figure 84. Global IDH1 Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global IDH1 Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global IDH1 Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global IDH1 Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global IDH1 Antibody Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IDH1 Antibody
Figure 2. IDH1 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IDH1 Antibody Sales Growth Rate 2021-2032 (ml)
Figure 7. Global IDH1 Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IDH1 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IDH1 Antibody Sales Market Share by Country/Region (2025)
Figure 10. IDH1 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal
Figure 12. Product Picture of Polyclonal
Figure 13. Global IDH1 Antibody Sales Market Share by Type in 2026
Figure 14. Global IDH1 Antibody Revenue Market Share by Type (2021-2026)
Figure 15. IDH1 Antibody Consumed in Immunochemistry (IHC)
Figure 16. Global IDH1 Antibody Market: Immunochemistry (IHC) (2021-2026) & (ml)
Figure 17. IDH1 Antibody Consumed in Immunofluorescence (IF)
Figure 18. Global IDH1 Antibody Market: Immunofluorescence (IF) (2021-2026) & (ml)
Figure 19. IDH1 Antibody Consumed in Immunoprecipitation (IP)
Figure 20. Global IDH1 Antibody Market: Immunoprecipitation (IP) (2021-2026) & (ml)
Figure 21. IDH1 Antibody Consumed in Western Blot (WB)
Figure 22. Global IDH1 Antibody Market: Western Blot (WB) (2021-2026) & (ml)
Figure 23. IDH1 Antibody Consumed in ELISA
Figure 24. Global IDH1 Antibody Market: ELISA (2021-2026) & (ml)
Figure 25. IDH1 Antibody Consumed in Others
Figure 26. Global IDH1 Antibody Market: Others (2021-2026) & (ml)
Figure 27. Global IDH1 Antibody Sale Market Share by Application (2025)
Figure 28. Global IDH1 Antibody Revenue Market Share by Application in 2026
Figure 29. IDH1 Antibody Sales by Company in 2026 (ml)
Figure 30. Global IDH1 Antibody Sales Market Share by Company in 2026
Figure 31. IDH1 Antibody Revenue by Company in 2026 ($ millions)
Figure 32. Global IDH1 Antibody Revenue Market Share by Company in 2026
Figure 33. Global IDH1 Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global IDH1 Antibody Revenue Market Share by Geographic Region in 2026
Figure 35. Americas IDH1 Antibody Sales 2021-2026 (ml)
Figure 36. Americas IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 37. APAC IDH1 Antibody Sales 2021-2026 (ml)
Figure 38. APAC IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 39. Europe IDH1 Antibody Sales 2021-2026 (ml)
Figure 40. Europe IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa IDH1 Antibody Sales 2021-2026 (ml)
Figure 42. Middle East & Africa IDH1 Antibody Revenue 2021-2026 ($ millions)
Figure 43. Americas IDH1 Antibody Sales Market Share by Country in 2026
Figure 44. Americas IDH1 Antibody Revenue Market Share by Country (2021-2026)
Figure 45. Americas IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 46. Americas IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 47. United States IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC IDH1 Antibody Sales Market Share by Region in 2026
Figure 52. APAC IDH1 Antibody Revenue Market Share by Region (2021-2026)
Figure 53. APAC IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 54. APAC IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 55. China IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. India IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe IDH1 Antibody Sales Market Share by Country in 2026
Figure 63. Europe IDH1 Antibody Revenue Market Share by Country (2021-2026)
Figure 64. Europe IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 65. Europe IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 66. Germany IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. France IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. UK IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa IDH1 Antibody Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa IDH1 Antibody Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa IDH1 Antibody Sales Market Share by Application (2021-2026)
Figure 74. Egypt IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries IDH1 Antibody Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of IDH1 Antibody in 2026
Figure 80. Manufacturing Process Analysis of IDH1 Antibody
Figure 81. Industry Chain Structure of IDH1 Antibody
Figure 82. Channels of Distribution
Figure 83. Global IDH1 Antibody Sales Market Forecast by Region (2027-2032)
Figure 84. Global IDH1 Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global IDH1 Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global IDH1 Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global IDH1 Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global IDH1 Antibody Revenue Market Share Forecast by Application (2027-2032)
